EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma
- DOI
- 10.1126/scitranslmed.adx8398
- Published
- 2026-07-08
- Container
- Science Translational Medicine
- Publisher
- American Association for the Advancement of Science (AAAS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1126/scitranslmed.adx8398,
title = {EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma},
author = {Arifa Nayab and Nouman Mughal and Meher Angez and Sansi Xing and Aarohan M. Burma and Harshitha Balla and Sani H. Kizilbash and Xiaoyao Yang and Muhammad Asad Maqbool and Fazal Arain and Azhar Hussain and Sahara Amir and Deepti Singh and Alyiah Karmali and Saif Somani and Toral R. Patel and Ankur Patel and Kimmo J. Hatanpaa and Michael Youssef and Nawal Shaikh and Carissa Ye and Dawen Zhao and Sandeep Burma and Jann N. Sarkaria and Nazanin K. Majd and Mansoor Saleh and Alain Charest and C. Ryan Miller and Louis B. Nabors and Mary Susmitha Kataru and Chandler E. Tolbert and Fatima Jimenez and Syed Ather Enam and Amyn A. Habib and Gao Guo},
year = {2026},
journal = {Science Translational Medicine},
doi = {10.1126/scitranslmed.adx8398},
url = {https://doi.org/10.1126/scitranslmed.adx8398}
}RIS
TY - JOUR TI - EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma AU - Arifa Nayab AU - Nouman Mughal AU - Meher Angez AU - Sansi Xing AU - Aarohan M. Burma AU - Harshitha Balla AU - Sani H. Kizilbash AU - Xiaoyao Yang AU - Muhammad Asad Maqbool AU - Fazal Arain AU - Azhar Hussain AU - Sahara Amir AU - Deepti Singh AU - Alyiah Karmali AU - Saif Somani AU - Toral R. Patel AU - Ankur Patel AU - Kimmo J. Hatanpaa AU - Michael Youssef AU - Nawal Shaikh AU - Carissa Ye AU - Dawen Zhao AU - Sandeep Burma AU - Jann N. Sarkaria AU - Nazanin K. Majd AU - Mansoor Saleh AU - Alain Charest AU - C. Ryan Miller AU - Louis B. Nabors AU - Mary Susmitha Kataru AU - Chandler E. Tolbert AU - Fatima Jimenez AU - Syed Ather Enam AU - Amyn A. Habib AU - Gao Guo PY - 2026 JO - Science Translational Medicine DO - 10.1126/scitranslmed.adx8398 UR - https://doi.org/10.1126/scitranslmed.adx8398 ER -
APA
Nayab, A., Mughal, N., Angez, M., Xing, S., Burma, A. M., Balla, H., Kizilbash, S. H., Yang, X., Maqbool, M. A., Arain, F., Hussain, A., Amir, S., Singh, D., Karmali, A., Somani, S., Patel, T. R., Patel, A., Hatanpaa, K. J., Youssef, M., Shaikh, N., Ye, C., Zhao, D., Burma, S., Sarkaria, J. N., Majd, N. K., Saleh, M., Charest, A., Miller, C. R., Nabors, L. B., Kataru, M. S., Tolbert, C. E., Jimenez, F., Enam, S. A., Habib, A. A., & Guo, G. (2026). EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adx8398
Source records
- crossref · retrieved 2026-09-26T16:44:49.473Z